Skip to main content
Fig. 4 | BMC Chemistry

Fig. 4

From: Structure–activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agents

Fig. 4

The results of MD simulations on 6a-VEGFR2 and sorafenib-VEGFR2 complexes. A. RMSD values of 6a-VEGFR2 and sorafenib-VEGFR2 complexes and 6a and sorafenib ligands during 0.5 ns equilibration and 50 ns production MD simulations. B. The total potential energy of 6a-VEGFR2 and sorafenib-VEGFR2 complexes during the MD simulation

Back to article page